New classification for identifying HR myeloma based on cytogenetic abnormalities
29 Oct 2024
New classification for identifying HR myeloma based on cytogenetic abnormalities
Revolutionising myeloma treatment through immune profiling
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Advancements in head and neck cancer treatment in India
Enhancing head and neck oncology: Key insights from the conference
Head & Neck - BMC Data
Choosing Wisely for young women with breast cancer: Radiotherapy